This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tuojie Biotech (Shanghai) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Changyong Yang: Innovator in Antibody-Drug Conjugates
Introduction
Changyong Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic agents.
Latest Patents
Changyong Yang holds a patent for an "ANTI-CD79B ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF." This invention represents a notable advancement in targeted cancer therapies, showcasing his expertise in antibody-drug conjugates. He has 1 patent to his name.
Career Highlights
Currently, Changyong Yang is associated with Tuojie Biotech (Shanghai) Co., Ltd. His work at this company emphasizes the importance of innovative solutions in the biotechnology sector. His research and development efforts are aimed at improving treatment options for patients.
Collaborations
Changyong Yang collaborates with notable colleagues, including Wenming Ren and Jindong Liang. Their combined expertise enhances the research and development initiatives at Tuojie Biotech.
Conclusion
Changyong Yang's contributions to the field of biotechnology, particularly through his patent on antibody-drug conjugates, highlight his role as an innovator. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile